Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 44 → 45·16:38, 27 Feb 2026
Difference between revision 44 and revision 45 of Qingdao Saber Technology Pharmaceutical. 2 lines changed; the page grew by 186 bytes.
| Revision 44 — 07:07, 17 Feb 2026 CheckSumChase (talk) add citation for the incidence figure 11,698 bytes ±0 | Revision 45 — 16:38, 27 Feb 2026 ShortageShona (talk) restructure 11,884 bytes +186 | ||
|---|---|---|---|
| 84 | Two frameworks are named in this article only to say what has ''not'' been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,{{r|gmp}} and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.{{r|iso17025}} Neither assessment is available here for this organisation or for any other covered on this wiki. | 84 | Two frameworks are named in this article only to say what has ''not'' been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,{{r|gmp}} and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.{{r|iso17025}} Neither assessment is available here for this organisation or for any other covered on this wiki. |
| 85 | 85 | ||
| + | 86 | The article's talk page carries the notability discussion in full, including the standing question of whether entities with no distinguishing features warrant separate articles at all. | |
| + | 87 | ||
| 86 | == References == | 88 | == References == |
| 87 | {{reflist}} | 89 | {{reflist}} |